Issue 11, 2015

A GGCT fluorogenic probe: design, synthesis and application to cancer-related cells

Abstract

Cancer-related γ-glutamyl cyclotransferase (GGCT) specifically converts γ-glutamyl amino acids (γ-Glu-Xaa) into pyroglutamate and the corresponding amino acids (Xaa). Here we report a novel GGCT fluorogenic probe “LISA-101” containing a masked O-acylated fluorophore “resorufin” on the side chain of the P1 amino acid (Xaa). Upon GGCT treatment, the P1 amino acid was liberated and spontaneously released the intact fluorophore. Thus, the fluorescence was regained. LISA-101 will expand the strategies for cancer studies.

Graphical abstract: A GGCT fluorogenic probe: design, synthesis and application to cancer-related cells

Supplementary files

Article information

Article type
Communication
Submitted
15 Jan 2015
Accepted
28 Jan 2015
First published
28 Jan 2015

Org. Biomol. Chem., 2015,13, 3182-3185

Author version available

A GGCT fluorogenic probe: design, synthesis and application to cancer-related cells

T. Yoshiya, H. Ii, S. Tsuda, S. Kageyama, T. Yoshiki and Y. Nishiuchi, Org. Biomol. Chem., 2015, 13, 3182 DOI: 10.1039/C5OB00086F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements